Timothée Olivier

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Coronary Artery Bypass

Top Venues

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Revue medicale suisse

This page only lists publications with an associated author ORCID identifier.

Publications

Timothée Olivier
[Interpreting a randomized trial in oncology: Key points for the clinician]. Revue medicale suisse 20 (874) (2024)
Timothée Olivier, Alyson Haslam, Patricia Burke, Isabelle Boutron, Florian Naudet, John P A Ioannidis, Vinay Prasad
A novel framework to assess haematology and oncology registration trials: The THEOREMM project. European journal of clinical investigation (2024)
Brian Schulte, Nicolas Mach, Timothée Olivier
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcomas: Looking Forward to What Is Next. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Brian Schulte, Nicolas Mach, Timothée Olivier
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcomas: Looking Forward to What Is Next. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Timothée Olivier, Alyson Haslam, Vinay Prasad
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer. BMC medicine 21 (1) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) 18 (36) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) 18 (36) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) 18 (36) (2023)
Kerrington Powell, John Marquart, Timothée Olivier, Vinay Prasad
The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial. Future oncology (London, England) (2023)
Timothée Olivier, Vinay Prasad
Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti-PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Timothée Olivier, Vinay Prasad
Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment. BMC medicine 20 (1) (2022)
Timothée Olivier, Vinay Prasad, Anthony J Perissinotti
Hard-wired biases in trials: maintenance azacitidine in patients with acute myeloid leukemia and framework for future trials. Blood advances 6 (11) (2022)